CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-06 | Halpin Michael Chief Operating Officer | Shares withheld for taxes | −931 | $33.91 | $32K | 6,747 |
| 2022-02-06 | Halpin Michael Chief Operating Officer | Option exercise · Restricted Stock Unit | −1,875 | $33.91 | $64K | 1,875 |
| 2022-02-06 | Colangelo Dominick President and CEO | Option exercise | +6,937 | 150,170 | ||
| 2022-02-06 | Colangelo Dominick President and CEO | Shares withheld for taxes | −3,049 | $33.91 | $103K | 147,121 |
| 2022-02-06 | Colangelo Dominick President and CEO | Option exercise · Restricted Stock Unit | −6,937 | $33.91 | $235K | 6,938 |
| 2021-12-31 | Mara Joseph Anthony Jr Chief Financial Officer | Option exercise | +4,000 | 12,787 | ||
| 2021-12-31 | Mara Joseph Anthony Jr Chief Financial Officer | Shares withheld for taxes | −1,174 | $39.30 | $46K | 11,613 |
| 2021-12-31 | Mara Joseph Anthony Jr Chief Financial Officer | Option exercise · Restricted Stock Unit | −4,000 | $39.30 | $157K | 0 |
| 2021-12-22 | Hopper Jonathan Mark Chief Medical Officer | Option exercise | +9,000 | $10.95 | $99K | 48,428 |
| 2021-12-22 | Hopper Jonathan Mark Chief Medical Officer | Sale | −9,000 | $40.14 | $361K | 39,428 |
| 2021-12-22 | Hopper Jonathan Mark Chief Medical Officer | Option exercise | +10,000 | $16.66 | $167K | 49,428 |
| 2021-12-22 | Hopper Jonathan Mark Chief Medical Officer | Sale | −5,881 | $40.08 | $236K | 43,547 |
| 2021-12-22 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Stock Option (right to buy) | −9,000 | 47,604 | ||
| 2021-12-22 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Stock Option (right to buy) | −10,000 | 16,000 | ||
| 2021-12-20 | Hopper Jonathan Mark Chief Medical Officer | Option exercise | +1,000 | $10.95 | $11K | 40,428 |
| 2021-12-20 | Hopper Jonathan Mark Chief Medical Officer | Sale | −1,000 | $40.00 | $40K | 39,428 |
| 2021-12-20 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Stock Option (right to buy) | −1,000 | 56,604 | ||
| 2021-11-29 | GILMAN STEVEN C Director | Option exercise | +5,000 | $3.74 | $19K | 8,500 |
| 2021-11-29 | GILMAN STEVEN C Director | Sale | −5,000 | $39.17 | $196K | 3,500 |
| 2021-11-29 | GILMAN STEVEN C Director | Option exercise · Stock Option (right to buy) | −5,000 | 0 |
Page 45 of 75 · 1,497 trades